SCHEMBL175227

SCHEMBL175227

C=CCN1CC[CH]CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10685204 0.91 ADRA2A (0.34)
SCHEMBL617496 0.85
SCHEMBL6692977 0.80 OPRD1 (0.41)
SCHEMBL290880 0.80
SCHEMBL3970107 0.80 OPRD1 (0.41)
SCHEMBL327601 0.80 OPRD1 (0.41)
Bromide SCHEMBL7969410 0.77 OPRD1 (0.40)
SCHEMBL1489209 0.75
SCHEMBL4957978 0.75
SCHEMBL88222 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 403 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023125376-A1 FUSED BICYCLIC HETEROARYL AMIDE COMPOUND AS PROTEIN AGGREGATION INHIBITOR 上海京新生物医药有限公司 2023-07-06 WO claimed
CN-108929268-B Chiral 1,2-diamine compound and synthetic method thereof 中国科学院上海有机化学研究所 2022-10-04 CN claimed
EP-3154941-B1 SMALL MOLECULE LFA-1 INHIBITORS ALLOCYTE PHARMACEUTICALS AG (CH) 2021-01-20 EP claimed
EP-3558971-A1 HISTONE METHYLTRANSFERASE INHIBITORS Global Blood Therapeutics, Inc. (US) 2019-10-30 EP claimed
US-20190040008-A1 SMALL MOLECULE LFA-1 INHIBITORS ALLOCYTE PHARMACEUTICALS AG (CH) 2019-02-07 US claimed
US-10077238-B2 Small molecule LFA-1 inhibitors ALLOCYTE PHARMACEUTICALS AG (CH) 2018-09-18 US claimed
WO-2018119208-A1 HISTONE METHYLTRANSFERASE INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. (US) 2018-06-28 WO claimed
US-20170121284-A1 SMALL MOLECULE LFA-1 INHIBITORS ALLOCYTE PHARMACEUTICALS AG (CH) 2017-05-04 US claimed
EP-2909193-B1 PHENYL LINKED QUINOLINYL MODULATORS OF ROR-GAMMA-T JANSSEN PHARMACEUTICA NV (BE) 2017-04-19 EP claimed
EP-3154941-A1 SMALL MOLECULE LFA-1 INHIBITORS AlloCyte Pharmaceuticals AG (CH) 2017-04-19 EP claimed
CN-1212695-A 4-amino pyrimidine derivates, medicament containing these compounds, their use THOMAE GMBH DR K (DE) 1999-03-31 CN claimed
US-5500435-A BENZIMIDAZOLES AND BENZOTRIAZOLES, TREATMENT OF RETINOID SENSITIVE SKIN DISORDERS JANSSEN PHARMACEUTICA, N.V. (BE) 1996-03-19 US claimed
EP-0366884-B1 Novel vinyl-terminated carbamylmethylated melamines, vinyl-terminated polyurethane/polyamide polymers and coating/adhesive compositions containing same CYTEC TECH CORP (US) 1996-01-03 EP claimed
US-5420147-A Benzimidazoles, benzotriazoles, controlling metabolism of retinoids, skin cancer JANSSEN PHARMACEUTICA N.V. (BE) 1995-05-30 US claimed
US-5157046-A Systemic or topical application of substituted benzimidazole or benzotriazole which suppresses retinoid metabolism JANSSEN PHARMACEUTICA N.V. (BE) 1992-10-20 US claimed
US-5066656-A Aromatase inhibitor, prevention of biosynthesis of estrogens, treatment of estrogen dependent disorders JANSSEN PHARMACEUTICA N.V. (BE) 1991-11-19 US claimed
EP-0371559-A2 Use of benzimidazoles in the treatment of epithelial disorders JANSSEN PHARMACEUTICA N.V. (BE) 1990-06-06 EP claimed
US-4866136-A 4-AMINOPIPERIDINE MODIFIED POLYANHYDRIDE PENNWALT CORPORATION (US) 1989-09-12 US claimed
US-4618599-A WATER SOLUBILITY RHONE-POULENC SANTE (FR) 1986-10-21 US claimed
EP-0079740-B1 ANTHRANILOYLOXYALKANOATES RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY (CH) 1985-11-13 EP claimed